nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—Clonazepam—NAT2—urinary bladder cancer	0.016	0.598	CrCbGaD
Bromazepam—CYP2C19—urine—urinary bladder cancer	0.0152	0.0992	CbGeAlD
Bromazepam—CYP1A2—urine—urinary bladder cancer	0.0124	0.081	CbGeAlD
Bromazepam—CYP2E1—urine—urinary bladder cancer	0.0111	0.0729	CbGeAlD
Bromazepam—Oxazepam—UGT2B7—urinary bladder cancer	0.0107	0.402	CrCbGaD
Bromazepam—GABRP—prostate gland—urinary bladder cancer	0.00972	0.0635	CbGeAlD
Bromazepam—CYP3A4—urine—urinary bladder cancer	0.00896	0.0586	CbGeAlD
Bromazepam—GABRE—prostate gland—urinary bladder cancer	0.00742	0.0485	CbGeAlD
Bromazepam—GABRP—urethra—urinary bladder cancer	0.0065	0.0425	CbGeAlD
Bromazepam—GABRB3—prostate gland—urinary bladder cancer	0.00629	0.0411	CbGeAlD
Bromazepam—GABRE—seminal vesicle—urinary bladder cancer	0.00627	0.041	CbGeAlD
Bromazepam—GABRB1—vagina—urinary bladder cancer	0.00535	0.035	CbGeAlD
Bromazepam—GABRP—female reproductive system—urinary bladder cancer	0.0053	0.0347	CbGeAlD
Bromazepam—GABRE—urethra—urinary bladder cancer	0.00497	0.0325	CbGeAlD
Bromazepam—GABRP—vagina—urinary bladder cancer	0.0048	0.0314	CbGeAlD
Bromazepam—Irritability—Cisplatin—urinary bladder cancer	0.00453	0.00685	CcSEcCtD
Bromazepam—Cardiac failure—Etoposide—urinary bladder cancer	0.00445	0.00674	CcSEcCtD
Bromazepam—GABRR2—lymph node—urinary bladder cancer	0.00444	0.029	CbGeAlD
Bromazepam—Muscular weakness—Fluorouracil—urinary bladder cancer	0.00441	0.00668	CcSEcCtD
Bromazepam—Asthenia—Mitomycin—urinary bladder cancer	0.00424	0.00642	CcSEcCtD
Bromazepam—Speech disorder—Methotrexate—urinary bladder cancer	0.00417	0.00631	CcSEcCtD
Bromazepam—Hallucination—Thiotepa—urinary bladder cancer	0.00416	0.0063	CcSEcCtD
Bromazepam—Cardiac arrest—Etoposide—urinary bladder cancer	0.00413	0.00626	CcSEcCtD
Bromazepam—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.00411	0.00623	CcSEcCtD
Bromazepam—GABRE—female reproductive system—urinary bladder cancer	0.00405	0.0265	CbGeAlD
Bromazepam—CYP2E1—prostate gland—urinary bladder cancer	0.004	0.0262	CbGeAlD
Bromazepam—Eye disorder—Thiotepa—urinary bladder cancer	0.00391	0.00592	CcSEcCtD
Bromazepam—Dizziness—Mitomycin—urinary bladder cancer	0.00391	0.00592	CcSEcCtD
Bromazepam—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00388	0.00588	CcSEcCtD
Bromazepam—Vomiting—Mitomycin—urinary bladder cancer	0.00376	0.00569	CcSEcCtD
Bromazepam—Rash—Mitomycin—urinary bladder cancer	0.00373	0.00564	CcSEcCtD
Bromazepam—Dermatitis—Mitomycin—urinary bladder cancer	0.00373	0.00564	CcSEcCtD
Bromazepam—Headache—Mitomycin—urinary bladder cancer	0.0037	0.00561	CcSEcCtD
Bromazepam—GABRA2—vagina—urinary bladder cancer	0.00369	0.0241	CbGeAlD
Bromazepam—Mental disorder—Thiotepa—urinary bladder cancer	0.00367	0.00555	CcSEcCtD
Bromazepam—GABRE—vagina—urinary bladder cancer	0.00366	0.0239	CbGeAlD
Bromazepam—Malnutrition—Thiotepa—urinary bladder cancer	0.00364	0.00552	CcSEcCtD
Bromazepam—Tension—Thiotepa—urinary bladder cancer	0.00358	0.00541	CcSEcCtD
Bromazepam—Nervousness—Thiotepa—urinary bladder cancer	0.00354	0.00536	CcSEcCtD
Bromazepam—Nausea—Mitomycin—urinary bladder cancer	0.00351	0.00532	CcSEcCtD
Bromazepam—Depressed level of consciousness—Methotrexate—urinary bladder cancer	0.00346	0.00524	CcSEcCtD
Bromazepam—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.00346	0.00524	CcSEcCtD
Bromazepam—Vision blurred—Thiotepa—urinary bladder cancer	0.00343	0.0052	CcSEcCtD
Bromazepam—GABRB3—female reproductive system—urinary bladder cancer	0.00343	0.0224	CbGeAlD
Bromazepam—CYP2E1—seminal vesicle—urinary bladder cancer	0.00338	0.0221	CbGeAlD
Bromazepam—Agitation—Thiotepa—urinary bladder cancer	0.00335	0.00507	CcSEcCtD
Bromazepam—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00327	0.00495	CcSEcCtD
Bromazepam—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.00323	0.00488	CcSEcCtD
Bromazepam—Convulsion—Thiotepa—urinary bladder cancer	0.00316	0.00478	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00308	0.00466	CcSEcCtD
Bromazepam—Eye disorder—Cisplatin—urinary bladder cancer	0.00307	0.00464	CcSEcCtD
Bromazepam—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00305	0.00461	CcSEcCtD
Bromazepam—CYP1A2—renal system—urinary bladder cancer	0.00303	0.0198	CbGeAlD
Bromazepam—Confusional state—Thiotepa—urinary bladder cancer	0.003	0.00454	CcSEcCtD
Bromazepam—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00292	0.00441	CcSEcCtD
Bromazepam—Tachycardia—Thiotepa—urinary bladder cancer	0.0029	0.00439	CcSEcCtD
Bromazepam—Skin disorder—Thiotepa—urinary bladder cancer	0.00289	0.00437	CcSEcCtD
Bromazepam—Malnutrition—Cisplatin—urinary bladder cancer	0.00286	0.00433	CcSEcCtD
Bromazepam—Vision blurred—Fluorouracil—urinary bladder cancer	0.00284	0.0043	CcSEcCtD
Bromazepam—Anorexia—Thiotepa—urinary bladder cancer	0.00283	0.00429	CcSEcCtD
Bromazepam—Eye disorder—Etoposide—urinary bladder cancer	0.00281	0.00425	CcSEcCtD
Bromazepam—Cardiac disorder—Etoposide—urinary bladder cancer	0.00279	0.00422	CcSEcCtD
Bromazepam—Muscle spasms—Cisplatin—urinary bladder cancer	0.00275	0.00416	CcSEcCtD
Bromazepam—CYP2E1—renal system—urinary bladder cancer	0.00273	0.0178	CbGeAlD
Bromazepam—Vision blurred—Cisplatin—urinary bladder cancer	0.00269	0.00408	CcSEcCtD
Bromazepam—CYP2C19—vagina—urinary bladder cancer	0.00269	0.0176	CbGeAlD
Bromazepam—CYP2E1—urethra—urinary bladder cancer	0.00268	0.0175	CbGeAlD
Bromazepam—Tremor—Cisplatin—urinary bladder cancer	0.00268	0.00405	CcSEcCtD
Bromazepam—Somnolence—Thiotepa—urinary bladder cancer	0.00264	0.004	CcSEcCtD
Bromazepam—Dyspepsia—Thiotepa—urinary bladder cancer	0.00262	0.00396	CcSEcCtD
Bromazepam—Convulsion—Fluorouracil—urinary bladder cancer	0.00261	0.00395	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00259	0.00392	CcSEcCtD
Bromazepam—Decreased appetite—Thiotepa—urinary bladder cancer	0.00259	0.00391	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00257	0.00389	CcSEcCtD
Bromazepam—Fatigue—Thiotepa—urinary bladder cancer	0.00256	0.00388	CcSEcCtD
Bromazepam—Muscle spasms—Etoposide—urinary bladder cancer	0.00252	0.00381	CcSEcCtD
Bromazepam—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.0025	0.00379	CcSEcCtD
Bromazepam—Cardiac failure—Epirubicin—urinary bladder cancer	0.0025	0.00378	CcSEcCtD
Bromazepam—Irritability—Methotrexate—urinary bladder cancer	0.00248	0.00376	CcSEcCtD
Bromazepam—Confusional state—Fluorouracil—urinary bladder cancer	0.00248	0.00375	CcSEcCtD
Bromazepam—Convulsion—Cisplatin—urinary bladder cancer	0.00248	0.00375	CcSEcCtD
Bromazepam—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00246	0.00372	CcSEcCtD
Bromazepam—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00245	0.00371	CcSEcCtD
Bromazepam—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00245	0.00371	CcSEcCtD
Bromazepam—Ataxia—Methotrexate—urinary bladder cancer	0.00245	0.00371	CcSEcCtD
Bromazepam—Diplopia—Epirubicin—urinary bladder cancer	0.00244	0.00369	CcSEcCtD
Bromazepam—Skin disorder—Gemcitabine—urinary bladder cancer	0.00243	0.00368	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00242	0.00366	CcSEcCtD
Bromazepam—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00241	0.00365	CcSEcCtD
Bromazepam—Tachycardia—Fluorouracil—urinary bladder cancer	0.0024	0.00363	CcSEcCtD
Bromazepam—GABRA2—lymph node—urinary bladder cancer	0.00239	0.0156	CbGeAlD
Bromazepam—Anorexia—Gemcitabine—urinary bladder cancer	0.00238	0.00361	CcSEcCtD
Bromazepam—GABRE—lymph node—urinary bladder cancer	0.00237	0.0155	CbGeAlD
Bromazepam—Anorexia—Fluorouracil—urinary bladder cancer	0.00234	0.00355	CcSEcCtD
Bromazepam—Hypotension—Gemcitabine—urinary bladder cancer	0.00234	0.00354	CcSEcCtD
Bromazepam—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00233	0.00353	CcSEcCtD
Bromazepam—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00232	0.00351	CcSEcCtD
Bromazepam—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00231	0.0035	CcSEcCtD
Bromazepam—Hypotension—Fluorouracil—urinary bladder cancer	0.0023	0.00348	CcSEcCtD
Bromazepam—Ataxia—Epirubicin—urinary bladder cancer	0.00229	0.00347	CcSEcCtD
Bromazepam—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00229	0.00346	CcSEcCtD
Bromazepam—Tachycardia—Cisplatin—urinary bladder cancer	0.00228	0.00345	CcSEcCtD
Bromazepam—Convulsion—Etoposide—urinary bladder cancer	0.00227	0.00343	CcSEcCtD
Bromazepam—Skin disorder—Cisplatin—urinary bladder cancer	0.00226	0.00343	CcSEcCtD
Bromazepam—Diplopia—Doxorubicin—urinary bladder cancer	0.00225	0.00341	CcSEcCtD
Bromazepam—Somnolence—Gemcitabine—urinary bladder cancer	0.00222	0.00337	CcSEcCtD
Bromazepam—Anorexia—Cisplatin—urinary bladder cancer	0.00222	0.00336	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00221	0.00335	CcSEcCtD
Bromazepam—CYP3A4—renal system—urinary bladder cancer	0.00219	0.0143	CbGeAlD
Bromazepam—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00219	0.00332	CcSEcCtD
Bromazepam—Somnolence—Fluorouracil—urinary bladder cancer	0.00219	0.00331	CcSEcCtD
Bromazepam—CYP2E1—female reproductive system—urinary bladder cancer	0.00218	0.0143	CbGeAlD
Bromazepam—Hypotension—Cisplatin—urinary bladder cancer	0.00218	0.0033	CcSEcCtD
Bromazepam—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00217	0.00329	CcSEcCtD
Bromazepam—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00217	0.00328	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00216	0.00327	CcSEcCtD
Bromazepam—Fatigue—Gemcitabine—urinary bladder cancer	0.00216	0.00326	CcSEcCtD
Bromazepam—Confusional state—Etoposide—urinary bladder cancer	0.00215	0.00326	CcSEcCtD
Bromazepam—Muscular weakness—Epirubicin—urinary bladder cancer	0.00215	0.00325	CcSEcCtD
Bromazepam—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00214	0.00324	CcSEcCtD
Bromazepam—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00214	0.00324	CcSEcCtD
Bromazepam—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00214	0.00323	CcSEcCtD
Bromazepam—Asthenia—Thiotepa—urinary bladder cancer	0.00213	0.00323	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00212	0.00321	CcSEcCtD
Bromazepam—Ataxia—Doxorubicin—urinary bladder cancer	0.00212	0.00321	CcSEcCtD
Bromazepam—Pruritus—Thiotepa—urinary bladder cancer	0.0021	0.00319	CcSEcCtD
Bromazepam—Tachycardia—Etoposide—urinary bladder cancer	0.00208	0.00316	CcSEcCtD
Bromazepam—Skin disorder—Etoposide—urinary bladder cancer	0.00207	0.00314	CcSEcCtD
Bromazepam—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00206	0.00312	CcSEcCtD
Bromazepam—Anorexia—Etoposide—urinary bladder cancer	0.00204	0.00308	CcSEcCtD
Bromazepam—Decreased appetite—Cisplatin—urinary bladder cancer	0.00203	0.00307	CcSEcCtD
Bromazepam—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00203	0.00307	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00201	0.00305	CcSEcCtD
Bromazepam—Drowsiness—Methotrexate—urinary bladder cancer	0.00201	0.00304	CcSEcCtD
Bromazepam—Hypotension—Etoposide—urinary bladder cancer	0.002	0.00302	CcSEcCtD
Bromazepam—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00199	0.00301	CcSEcCtD
Bromazepam—Dizziness—Thiotepa—urinary bladder cancer	0.00197	0.00298	CcSEcCtD
Bromazepam—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00192	0.00291	CcSEcCtD
Bromazepam—Somnolence—Etoposide—urinary bladder cancer	0.0019	0.00287	CcSEcCtD
Bromazepam—Vomiting—Thiotepa—urinary bladder cancer	0.00189	0.00286	CcSEcCtD
Bromazepam—Drowsiness—Epirubicin—urinary bladder cancer	0.00188	0.00284	CcSEcCtD
Bromazepam—Rash—Thiotepa—urinary bladder cancer	0.00188	0.00284	CcSEcCtD
Bromazepam—Dermatitis—Thiotepa—urinary bladder cancer	0.00187	0.00284	CcSEcCtD
Bromazepam—Headache—Thiotepa—urinary bladder cancer	0.00186	0.00282	CcSEcCtD
Bromazepam—Decreased appetite—Etoposide—urinary bladder cancer	0.00186	0.00281	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00184	0.00279	CcSEcCtD
Bromazepam—Fatigue—Etoposide—urinary bladder cancer	0.00184	0.00279	CcSEcCtD
Bromazepam—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00181	0.00274	CcSEcCtD
Bromazepam—Asthenia—Gemcitabine—urinary bladder cancer	0.00179	0.00272	CcSEcCtD
Bromazepam—Pruritus—Gemcitabine—urinary bladder cancer	0.00177	0.00268	CcSEcCtD
Bromazepam—Nausea—Thiotepa—urinary bladder cancer	0.00177	0.00267	CcSEcCtD
Bromazepam—Feeling abnormal—Etoposide—urinary bladder cancer	0.00176	0.00266	CcSEcCtD
Bromazepam—CYP3A4—female reproductive system—urinary bladder cancer	0.00176	0.0115	CbGeAlD
Bromazepam—Pruritus—Fluorouracil—urinary bladder cancer	0.00174	0.00263	CcSEcCtD
Bromazepam—Drowsiness—Doxorubicin—urinary bladder cancer	0.00174	0.00263	CcSEcCtD
Bromazepam—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00172	0.0026	CcSEcCtD
Bromazepam—Eye disorder—Methotrexate—urinary bladder cancer	0.00168	0.00255	CcSEcCtD
Bromazepam—Asthenia—Cisplatin—urinary bladder cancer	0.00167	0.00253	CcSEcCtD
Bromazepam—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00167	0.00253	CcSEcCtD
Bromazepam—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00166	0.00251	CcSEcCtD
Bromazepam—Dizziness—Fluorouracil—urinary bladder cancer	0.00163	0.00246	CcSEcCtD
Bromazepam—Vomiting—Gemcitabine—urinary bladder cancer	0.00159	0.00241	CcSEcCtD
Bromazepam—Mental disorder—Methotrexate—urinary bladder cancer	0.00158	0.00239	CcSEcCtD
Bromazepam—Rash—Gemcitabine—urinary bladder cancer	0.00158	0.00239	CcSEcCtD
Bromazepam—Dermatitis—Gemcitabine—urinary bladder cancer	0.00158	0.00239	CcSEcCtD
Bromazepam—Eye disorder—Epirubicin—urinary bladder cancer	0.00158	0.00238	CcSEcCtD
Bromazepam—Hypersensitivity—Etoposide—urinary bladder cancer	0.00157	0.00238	CcSEcCtD
Bromazepam—Malnutrition—Methotrexate—urinary bladder cancer	0.00157	0.00237	CcSEcCtD
Bromazepam—Headache—Gemcitabine—urinary bladder cancer	0.00157	0.00237	CcSEcCtD
Bromazepam—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00156	0.00237	CcSEcCtD
Bromazepam—Vomiting—Fluorouracil—urinary bladder cancer	0.00156	0.00237	CcSEcCtD
Bromazepam—Rash—Fluorouracil—urinary bladder cancer	0.00155	0.00235	CcSEcCtD
Bromazepam—Dermatitis—Fluorouracil—urinary bladder cancer	0.00155	0.00235	CcSEcCtD
Bromazepam—Headache—Fluorouracil—urinary bladder cancer	0.00154	0.00233	CcSEcCtD
Bromazepam—Asthenia—Etoposide—urinary bladder cancer	0.00153	0.00232	CcSEcCtD
Bromazepam—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00153	0.00232	CcSEcCtD
Bromazepam—Pruritus—Etoposide—urinary bladder cancer	0.00151	0.00229	CcSEcCtD
Bromazepam—Nausea—Gemcitabine—urinary bladder cancer	0.00149	0.00225	CcSEcCtD
Bromazepam—Vomiting—Cisplatin—urinary bladder cancer	0.00148	0.00224	CcSEcCtD
Bromazepam—Vision blurred—Methotrexate—urinary bladder cancer	0.00148	0.00224	CcSEcCtD
Bromazepam—Mental disorder—Epirubicin—urinary bladder cancer	0.00148	0.00224	CcSEcCtD
Bromazepam—Rash—Cisplatin—urinary bladder cancer	0.00147	0.00223	CcSEcCtD
Bromazepam—Dermatitis—Cisplatin—urinary bladder cancer	0.00147	0.00222	CcSEcCtD
Bromazepam—Malnutrition—Epirubicin—urinary bladder cancer	0.00147	0.00222	CcSEcCtD
Bromazepam—Nausea—Fluorouracil—urinary bladder cancer	0.00146	0.00221	CcSEcCtD
Bromazepam—Eye disorder—Doxorubicin—urinary bladder cancer	0.00146	0.00221	CcSEcCtD
Bromazepam—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00145	0.00219	CcSEcCtD
Bromazepam—Tension—Epirubicin—urinary bladder cancer	0.00144	0.00218	CcSEcCtD
Bromazepam—Nervousness—Epirubicin—urinary bladder cancer	0.00143	0.00216	CcSEcCtD
Bromazepam—Dizziness—Etoposide—urinary bladder cancer	0.00141	0.00214	CcSEcCtD
Bromazepam—Muscle spasms—Epirubicin—urinary bladder cancer	0.00141	0.00214	CcSEcCtD
Bromazepam—Nausea—Cisplatin—urinary bladder cancer	0.00139	0.0021	CcSEcCtD
Bromazepam—Vision blurred—Epirubicin—urinary bladder cancer	0.00138	0.00209	CcSEcCtD
Bromazepam—Mental disorder—Doxorubicin—urinary bladder cancer	0.00137	0.00207	CcSEcCtD
Bromazepam—Convulsion—Methotrexate—urinary bladder cancer	0.00136	0.00206	CcSEcCtD
Bromazepam—Vomiting—Etoposide—urinary bladder cancer	0.00136	0.00206	CcSEcCtD
Bromazepam—Malnutrition—Doxorubicin—urinary bladder cancer	0.00136	0.00206	CcSEcCtD
Bromazepam—Agitation—Epirubicin—urinary bladder cancer	0.00135	0.00204	CcSEcCtD
Bromazepam—Rash—Etoposide—urinary bladder cancer	0.00135	0.00204	CcSEcCtD
Bromazepam—Dermatitis—Etoposide—urinary bladder cancer	0.00135	0.00204	CcSEcCtD
Bromazepam—Headache—Etoposide—urinary bladder cancer	0.00134	0.00203	CcSEcCtD
Bromazepam—Tension—Doxorubicin—urinary bladder cancer	0.00133	0.00202	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00133	0.00201	CcSEcCtD
Bromazepam—Nervousness—Doxorubicin—urinary bladder cancer	0.00132	0.002	CcSEcCtD
Bromazepam—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00131	0.00198	CcSEcCtD
Bromazepam—Palpitations—Epirubicin—urinary bladder cancer	0.0013	0.00196	CcSEcCtD
Bromazepam—Confusional state—Methotrexate—urinary bladder cancer	0.00129	0.00195	CcSEcCtD
Bromazepam—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00128	0.00194	CcSEcCtD
Bromazepam—Vision blurred—Doxorubicin—urinary bladder cancer	0.00128	0.00194	CcSEcCtD
Bromazepam—Convulsion—Epirubicin—urinary bladder cancer	0.00127	0.00192	CcSEcCtD
Bromazepam—Nausea—Etoposide—urinary bladder cancer	0.00127	0.00192	CcSEcCtD
Bromazepam—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00125	0.0019	CcSEcCtD
Bromazepam—Agitation—Doxorubicin—urinary bladder cancer	0.00125	0.00189	CcSEcCtD
Bromazepam—Skin disorder—Methotrexate—urinary bladder cancer	0.00124	0.00188	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00124	0.00188	CcSEcCtD
Bromazepam—Dry mouth—Epirubicin—urinary bladder cancer	0.00122	0.00185	CcSEcCtD
Bromazepam—Anorexia—Methotrexate—urinary bladder cancer	0.00122	0.00185	CcSEcCtD
Bromazepam—Confusional state—Epirubicin—urinary bladder cancer	0.00121	0.00183	CcSEcCtD
Bromazepam—Palpitations—Doxorubicin—urinary bladder cancer	0.0012	0.00182	CcSEcCtD
Bromazepam—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.0012	0.00181	CcSEcCtD
Bromazepam—Hypotension—Methotrexate—urinary bladder cancer	0.0012	0.00181	CcSEcCtD
Bromazepam—Convulsion—Doxorubicin—urinary bladder cancer	0.00118	0.00178	CcSEcCtD
Bromazepam—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00117	0.00178	CcSEcCtD
Bromazepam—Tachycardia—Epirubicin—urinary bladder cancer	0.00117	0.00177	CcSEcCtD
Bromazepam—Skin disorder—Epirubicin—urinary bladder cancer	0.00116	0.00176	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00115	0.00174	CcSEcCtD
Bromazepam—Anorexia—Epirubicin—urinary bladder cancer	0.00114	0.00173	CcSEcCtD
Bromazepam—Somnolence—Methotrexate—urinary bladder cancer	0.00114	0.00172	CcSEcCtD
Bromazepam—Dry mouth—Doxorubicin—urinary bladder cancer	0.00113	0.00171	CcSEcCtD
Bromazepam—Dyspepsia—Methotrexate—urinary bladder cancer	0.00113	0.00171	CcSEcCtD
Bromazepam—Hypotension—Epirubicin—urinary bladder cancer	0.00112	0.00169	CcSEcCtD
Bromazepam—Confusional state—Doxorubicin—urinary bladder cancer	0.00112	0.00169	CcSEcCtD
Bromazepam—Decreased appetite—Methotrexate—urinary bladder cancer	0.00111	0.00168	CcSEcCtD
Bromazepam—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00111	0.00168	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.0011	0.00167	CcSEcCtD
Bromazepam—Fatigue—Methotrexate—urinary bladder cancer	0.0011	0.00167	CcSEcCtD
Bromazepam—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00109	0.00164	CcSEcCtD
Bromazepam—Tachycardia—Doxorubicin—urinary bladder cancer	0.00108	0.00164	CcSEcCtD
Bromazepam—Skin disorder—Doxorubicin—urinary bladder cancer	0.00108	0.00163	CcSEcCtD
Bromazepam—Somnolence—Epirubicin—urinary bladder cancer	0.00106	0.00161	CcSEcCtD
Bromazepam—Anorexia—Doxorubicin—urinary bladder cancer	0.00106	0.0016	CcSEcCtD
Bromazepam—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00105	0.0016	CcSEcCtD
Bromazepam—Dyspepsia—Epirubicin—urinary bladder cancer	0.00105	0.0016	CcSEcCtD
Bromazepam—Decreased appetite—Epirubicin—urinary bladder cancer	0.00104	0.00158	CcSEcCtD
Bromazepam—Hypotension—Doxorubicin—urinary bladder cancer	0.00104	0.00157	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00103	0.00156	CcSEcCtD
Bromazepam—Fatigue—Epirubicin—urinary bladder cancer	0.00103	0.00156	CcSEcCtD
Bromazepam—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000987	0.00149	CcSEcCtD
Bromazepam—Somnolence—Doxorubicin—urinary bladder cancer	0.000985	0.00149	CcSEcCtD
Bromazepam—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000975	0.00148	CcSEcCtD
Bromazepam—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000963	0.00146	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000957	0.00145	CcSEcCtD
Bromazepam—Fatigue—Doxorubicin—urinary bladder cancer	0.000955	0.00145	CcSEcCtD
Bromazepam—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000943	0.00143	CcSEcCtD
Bromazepam—Asthenia—Methotrexate—urinary bladder cancer	0.000918	0.00139	CcSEcCtD
Bromazepam—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000913	0.00138	CcSEcCtD
Bromazepam—Pruritus—Methotrexate—urinary bladder cancer	0.000905	0.00137	CcSEcCtD
Bromazepam—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000882	0.00134	CcSEcCtD
Bromazepam—Asthenia—Epirubicin—urinary bladder cancer	0.000859	0.0013	CcSEcCtD
Bromazepam—Pruritus—Epirubicin—urinary bladder cancer	0.000847	0.00128	CcSEcCtD
Bromazepam—Dizziness—Methotrexate—urinary bladder cancer	0.000846	0.00128	CcSEcCtD
Bromazepam—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000816	0.00124	CcSEcCtD
Bromazepam—Vomiting—Methotrexate—urinary bladder cancer	0.000814	0.00123	CcSEcCtD
Bromazepam—Rash—Methotrexate—urinary bladder cancer	0.000807	0.00122	CcSEcCtD
Bromazepam—Dermatitis—Methotrexate—urinary bladder cancer	0.000806	0.00122	CcSEcCtD
Bromazepam—Headache—Methotrexate—urinary bladder cancer	0.000802	0.00121	CcSEcCtD
Bromazepam—Asthenia—Doxorubicin—urinary bladder cancer	0.000795	0.0012	CcSEcCtD
Bromazepam—Dizziness—Epirubicin—urinary bladder cancer	0.000792	0.0012	CcSEcCtD
Bromazepam—Pruritus—Doxorubicin—urinary bladder cancer	0.000784	0.00119	CcSEcCtD
Bromazepam—Vomiting—Epirubicin—urinary bladder cancer	0.000761	0.00115	CcSEcCtD
Bromazepam—Nausea—Methotrexate—urinary bladder cancer	0.00076	0.00115	CcSEcCtD
Bromazepam—Rash—Epirubicin—urinary bladder cancer	0.000755	0.00114	CcSEcCtD
Bromazepam—Dermatitis—Epirubicin—urinary bladder cancer	0.000754	0.00114	CcSEcCtD
Bromazepam—Headache—Epirubicin—urinary bladder cancer	0.00075	0.00114	CcSEcCtD
Bromazepam—Dizziness—Doxorubicin—urinary bladder cancer	0.000733	0.00111	CcSEcCtD
Bromazepam—Nausea—Epirubicin—urinary bladder cancer	0.000711	0.00108	CcSEcCtD
Bromazepam—Vomiting—Doxorubicin—urinary bladder cancer	0.000704	0.00107	CcSEcCtD
Bromazepam—Rash—Doxorubicin—urinary bladder cancer	0.000699	0.00106	CcSEcCtD
Bromazepam—Dermatitis—Doxorubicin—urinary bladder cancer	0.000698	0.00106	CcSEcCtD
Bromazepam—Headache—Doxorubicin—urinary bladder cancer	0.000694	0.00105	CcSEcCtD
Bromazepam—Nausea—Doxorubicin—urinary bladder cancer	0.000658	0.000996	CcSEcCtD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000312	0.00195	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000306	0.00192	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000304	0.0019	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000301	0.00188	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000299	0.00187	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000299	0.00187	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000294	0.00184	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000292	0.00182	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000268	0.00168	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000262	0.00164	CbGpPWpGaD
Bromazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000261	0.00164	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.00026	0.00163	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000258	0.00161	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000258	0.00161	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000257	0.00161	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000255	0.00159	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000254	0.00159	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000251	0.00157	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.00024	0.0015	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00024	0.0015	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00024	0.0015	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000237	0.00148	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000234	0.00146	CbGpPWpGaD
Bromazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000231	0.00145	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000231	0.00144	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000221	0.00138	CbGpPWpGaD
Bromazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.00022	0.00138	CbGpPWpGaD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.00022	0.00138	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000217	0.00136	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000215	0.00135	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000212	0.00133	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000211	0.00132	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000209	0.00131	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000209	0.00131	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000207	0.00129	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000203	0.00127	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000203	0.00127	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000202	0.00126	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000202	0.00126	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000199	0.00125	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000198	0.00124	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	0.000198	0.00124	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000196	0.00122	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000194	0.00121	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000194	0.00121	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000191	0.00119	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000183	0.00114	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000181	0.00114	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.00018	0.00113	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000179	0.00112	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000178	0.00111	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000174	0.00109	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000174	0.00109	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000174	0.00109	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000173	0.00108	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000169	0.00106	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000169	0.00106	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000169	0.00106	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000167	0.00105	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000166	0.00104	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000166	0.00104	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000166	0.00104	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000164	0.00102	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000164	0.00102	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000161	0.00101	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000157	0.00098	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000153	0.00096	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000153	0.000956	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000152	0.000949	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000151	0.000945	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000148	0.000929	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000148	0.000928	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000148	0.000928	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000146	0.000916	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000146	0.000916	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000146	0.000912	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000143	0.000897	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000143	0.000896	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000142	0.00089	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000141	0.000884	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000141	0.000884	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000141	0.00088	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.00014	0.000877	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.00014	0.000874	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	0.000139	0.00087	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000139	0.000868	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000136	0.000854	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000136	0.00085	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000136	0.00085	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000134	0.000841	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—HRAS—urinary bladder cancer	0.000133	0.000833	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000133	0.000831	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000129	0.000809	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000127	0.000798	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000127	0.000796	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—HRAS—urinary bladder cancer	0.000127	0.000794	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—HRAS—urinary bladder cancer	0.000127	0.000794	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000126	0.000786	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.000124	0.000778	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000122	0.000764	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000121	0.000754	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000119	0.000745	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000119	0.000743	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000115	0.000719	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000112	0.000703	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.000112	0.0007	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000112	0.000698	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000111	0.000694	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000111	0.000692	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.00011	0.000685	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000109	0.000679	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000108	0.000674	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000107	0.00067	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000107	0.000669	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000106	0.000661	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000105	0.000657	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000105	0.000656	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000105	0.000656	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—HRAS—urinary bladder cancer	0.000105	0.000654	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000103	0.000645	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—HRAS—urinary bladder cancer	0.000103	0.000644	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000103	0.000644	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000101	0.000635	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.97e-05	0.000624	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.86e-05	0.000617	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.84e-05	0.000616	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—HRAS—urinary bladder cancer	9.74e-05	0.00061	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.68e-05	0.000606	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—HRAS—urinary bladder cancer	9.62e-05	0.000602	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	9.59e-05	0.0006	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.51e-05	0.000595	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.45e-05	0.000591	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.28e-05	0.000581	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.18e-05	0.000574	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—HRAS—urinary bladder cancer	8.8e-05	0.000551	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	8.63e-05	0.00054	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	8.62e-05	0.000539	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—HRAS—urinary bladder cancer	8.55e-05	0.000535	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—HRAS—urinary bladder cancer	8.39e-05	0.000525	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—HRAS—urinary bladder cancer	8.25e-05	0.000516	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TYMP—urinary bladder cancer	8.23e-05	0.000515	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—HRAS—urinary bladder cancer	8.19e-05	0.000513	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	8.17e-05	0.000511	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NAT1—urinary bladder cancer	8.17e-05	0.000511	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	8.15e-05	0.00051	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.11e-05	0.000508	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—HRAS—urinary bladder cancer	8.05e-05	0.000504	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.03e-05	0.000503	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	7.94e-05	0.000497	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	7.47e-05	0.000467	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NAT2—urinary bladder cancer	7.44e-05	0.000466	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—HRAS—urinary bladder cancer	7.03e-05	0.00044	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	6.73e-05	0.000421	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.65e-05	0.000416	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—RRM2—urinary bladder cancer	6.43e-05	0.000402	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.37e-05	0.000399	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	6.35e-05	0.000397	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.35e-05	0.000397	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.3e-05	0.000394	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.3e-05	0.000394	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	6.19e-05	0.000387	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.1e-05	0.000382	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	5.95e-05	0.000372	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ENO2—urinary bladder cancer	5.95e-05	0.000372	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	5.77e-05	0.000361	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.76e-05	0.000361	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NAT2—urinary bladder cancer	5.74e-05	0.000359	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.19e-05	0.000325	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.96e-05	0.000311	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.96e-05	0.00031	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TYMP—urinary bladder cancer	4.95e-05	0.00031	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.9e-05	0.000307	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NQO1—urinary bladder cancer	4.8e-05	0.0003	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.78e-05	0.000299	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.75e-05	0.000297	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.59e-05	0.000287	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.59e-05	0.000287	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.56e-05	0.000286	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.47e-05	0.00028	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.45e-05	0.000279	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.38e-05	0.000274	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	4e-05	0.00025	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.86e-05	0.000242	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.82e-05	0.000239	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3.72e-05	0.000233	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.7e-05	0.000232	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.68e-05	0.00023	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.68e-05	0.00023	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.59e-05	0.000225	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.58e-05	0.000224	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.58e-05	0.000224	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.56e-05	0.000223	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.52e-05	0.00022	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.47e-05	0.000217	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.46e-05	0.000216	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.45e-05	0.000216	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.42e-05	0.000214	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	3.25e-05	0.000203	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.13e-05	0.000196	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.09e-05	0.000193	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.99e-05	0.000187	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.98e-05	0.000187	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.88e-05	0.00018	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.87e-05	0.00018	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.84e-05	0.000177	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.84e-05	0.000177	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.8e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.76e-05	0.000173	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.76e-05	0.000173	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.72e-05	0.00017	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.68e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.67e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.63e-05	0.000165	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.53e-05	0.000158	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.51e-05	0.000157	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.44e-05	0.000153	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.41e-05	0.00015	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.33e-05	0.000146	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.24e-05	0.00014	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.23e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.21e-05	0.000138	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.21e-05	0.000138	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.12e-05	0.000132	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.08e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	2.07e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.03e-05	0.000127	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.95e-05	0.000122	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.95e-05	0.000122	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.86e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.81e-05	0.000113	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.73e-05	0.000108	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.72e-05	0.000108	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.71e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.71e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.63e-05	0.000102	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.6e-05	0.0001	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.6e-05	0.0001	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.58e-05	9.91e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.52e-05	9.52e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.51e-05	9.43e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.39e-05	8.73e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.33e-05	8.32e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	7.8e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.22e-05	7.65e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.17e-05	7.35e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.09e-05	6.8e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.04e-05	6.48e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.62e-06	6.02e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.39e-06	5.25e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—EP300—urinary bladder cancer	8e-06	5e-05	CbGpPWpGaD
